Robocard P5
₹1,750
Robocard P5 is indicated for the management of the signs of mild, moderate, or severe (modified NYHA Class IIa, IIIb, or IVc) congestive heart failure in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM).
Estimated Delivery Date: January 24, 2025
While the original Robocard variant contains both pimobendan 5 mg and benazepril 10 mg in each tablet, this Robocard P5 variant contains pimobendan 5 mg only. It is intended for dogs and puppies who have been prescribed pimobendan only and not the ACE inhibitor benazepril.
Pimobendan is an inotropic (heart stimulant) substance that increases the strength of the contraction of the heart muscle and opens up blood vessels carrying blood to and from the heart, which reduces the workload of the heart.
Features:
Robocard P5 is indicated for the management of the signs of mild, moderate, or severe (modified NYHA Class IIa, IIIb, or IVc) congestive heart failure in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM).
Pimobendan is an inotropic (heart stimulant) substance that increases the strength of the contraction of the heart muscle and opens up blood vessels carrying blood to and from the heart, which reduces the workload of the heart.
Benazepril is a prodrug, a substance that is converted to benazeprilat in the body. Benazeprilat is an angiotensin-converting enzyme (ACE) inhibitor. ACE inhibitors lower the production of angiotensin II, a powerful vasoconstrictor (a substance that narrows blood vessels). When the production of angiotensin II is lowered, the blood vessels relax and widen. This allows the blood pressure to drop, reducing the load on the heart.
Both pimobendan and benazepril are already authorized for dogs as separate medicines.
Direction of Use
NA
Precautions
NA
General Inquiries
There are no inquiries yet.
Home 
Whishlist 
Compare 
Checkout 
Account
Reviews
There are no reviews yet.